National/International Accreditations
AXIS Clinicals has been audited and approved by various regulatory authorities that include:
- Drugs Controller General of India
- US-FDA
- EMEA
- UK-MHRA
- AFSSAPS, France
- ANVISA, Brazil
- MCC, South Africa
- MOH, Turkey
- MOH, Mexico
- Thailand FDA
- WHO
- GCC-DR ( Gulf Central Committee for Drug Registration)
- NPRA Malaysia
- AEMPS Spain
- INFARMED Portugal
Medical Diagnostic Lab of AXIS Clinicals has been approved and accredited by NABL on annual basis. Besides study submissions to more than 25 countries, AXIS Clinicals has also been approved for submission of studies to MOH Canada, NPCB Malaysia, Australia, South Africa and WHO.
